Logo - springer
Slogan - springer

Public Health | Journal of Cancer Survivorship - incl. option to publish open access (Editorial Board)

Journal of Cancer Survivorship

Journal of Cancer Survivorship

Research and Practice

Editor: Michael Feuerstein

ISSN: 1932-2259 (print version)
ISSN: 1932-2267 (electronic version)

Journal no. 11764

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 6 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Editor in Chief

Michael Feuerstein, Ph.D., MPH

Departments of Medical and Clinical Psychology and Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD

Associate Editors

Neil K. Aaronson, Ph.D., The Netherlands Cancer Institute, Amsterdam

Saskia F.A. Duijts, Ph.D., University Medical Center Groningen, Amsterdam University Medical Center, The Netherlands

Shawna  Hudson, Ph.D., UMDNJ- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

Jennifer M. Jones, Ph.D., Toronto General Research Institute, Toronto, Ontario, Canada

Justin Keogh, Ph.D., Bond University, Robina, Queensland, Australia

Brad Love, Ph.D., Center for Health Communication, University of Texas, Austin, TX

Anja Mehnert, Ph.D., University Medical Center Leipzig, Leipzig, Germany

Larissa Nakhlyudov, MD, MPH, Harvard Medical School, Boston, MA

Paul Nathan MD, MSc, The Hospital for Sick Children, Toronto, ON

Katherine Smith, Ph.D., Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

Karen L. Syrjala, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, WA

Amye Tevaarwerk, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

Xinhua Yu, MD, Ph.D., MSc, University of Memphis School of Public Health, Memphis, TN

 Editorial Board

Tim A. Ahles, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NY; Kathy B. Baumgartner, Ph.D., Health Sciences Center, University of Louisville, Louisville, KY; Joan Bloom, Ph.D., UC Berkley, Berkley, CACathy J. Bradley, MPA, Ph.D., Medical College of Virginia, Virginia Commonwealth University, Richmond, VA; Linda E. Carlson, Ph.D., University of Calgary, Calgary, AB, Canada; David Cella, Ph.D., Northwestern University, Feinberg School of Medicine,Chicago, IL; Victor T. Chang, MD, VA New Jersey Health Care System, East Orange, NJJessica Chubak, Ph.D., Group Health Research Institute, Seattle, WA; Charles S. Cleeland, Ph.D., MD, Anderson Cancer Center, Houston, TX; Kerry S. Courneya, Ph.D., University of Alberta, Edmonton, Canada;  Wendy Demark-Wahnefried, Ph.D., RD, University of Alabama at Birmingham, Birmingham, ALCraig C. Earle, MD, MSc, Dana Farber Cancer Institute, Boston, MA; Karen M. Freund, MD, MPH, Boston University School of Medicine, Boston, MA; Patricia A. Ganz, MD, University of California Los Angeles, Schools of Medicine and Public Health, Los Angeles, CA;  Marcia Grant, RN, DNSc, City of Hope Medical Center, Duarte, CADonna B. Greenberg, MD, Dana Farber Cancer Center, Boston, MA; Diana Greenfield, RN, Ph.D., Weston Park Hospital, Sheffield, UK; Jimmie C. Holland, MD, Memorial Sloan Kettering Cancer Center, New York, NY; Melissa M. Hudson, MD, St. Jude Children’s Research Hospital, Memphis, TNLinda A. Jacobs, Ph.D., RN, Ambramson Cancer Center, University of Pennsylvania, Philadelphia, PA;  Paul B. Jacobsen, Ph.D., H. Lee Moffitt Cancer Center, Tampa, FL; Gary L. Kreps, Ph.D., George Mason University, Fairfax,VA; Kate R. Lorig, RN, DrPH, Stanford University School of Medicine, Stanford, CA; Jeanne S. Madelblatt, MD, MPH, Georgetown University School of Medicine, Washington, DC; Jun J. Mao, MD, MSCE, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA; Elizabeth Maunsell, Ph.D., Faculté de médecine, Université Laval, Quebec City, QC, CanadaAndrew H. Miller, MD, Emory University School of Medicine, Atlanta, GAKevin C. Oeffinger, MD; Duke University Medical Center, Durham, NC; Jamie S. Ostroff, Ph.D., Memorial Sloan Kettering Cancer Center, New York, NYJeffrey Peppercorn, MD, MPH, Harvard Medical School, Boston, MA; Gwendolyn P. Quinn, Ph.D., H. Lee Moffitt Cancer Center, Tampa, FL; Carolyn S. Rabin, Ph.D., William James College, Newton, MALeslie L. Robison, Ph.D., St. Jude Children’s Research Hospital, Memphis, TN; Julia H. Rowland, Ph.D., National Cancer Institute, National Institutes of Health, Bethesda, MDCharles L. Shapiro, MD, Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, OH; Pamela F. Short, Ph.D., Penn State University, University Park, PA; Annette L. Stanton, Ph.D., University of California Los Angeles, Los Angeles, CA;   Umberto Tirelli, MD, National Cancer Institute, Aviano, Italy; Peter C. Trask, Ph.D., MPH, Brown Medical School, Providence, RI; Jos H.Verbeek, MD, Amsterdam University, Amsterdam, The Netherlands; Diane Von Ah, Ph.D., RN, FAAN, Indiana University, School of Nursing, Indianapolis, IN; Edward H.Wagner, MD, MPH, MacColl Institute for Health Care Innovation, Group Health Cooperative, Seattle, WA; K. Robin Yabroff, Ph.D., Office of Health Policy, Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Bethesda, MD; Brad J. Zebrack, Ph.D., MSW, MPH, University of Michigan, Ann Arbor, MI

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 3.713
  • Aims and Scope

    Aims and Scope


    Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Author Academy: Training for Authors
  • Compliance with Ethical Requirements
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Alerts for this journal


Get the table of contents of every new issue published in Journal of Cancer Survivorship.